MedPath

Pilot Study on the Submental Area

Not Applicable
Completed
Conditions
Body Fat Disorder
Registration Number
NCT01859091
Lead Sponsor
Zeltiq Aesthetics
Brief Summary

The purpose of this study is to evaluate the safety and feasibility of cryolipolysis for non-invasive reduction of submental fat.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Evaluate safety of treatment times8-weeks post treatment

The primary objective of this study is to evaluate the safety of submental fat reduction with the ZELTIQ System. Safety is defined as incidence of device- and/or procedure-related adverse events.

Secondary Outcome Measures
NameTimeMethod
Reduction measured by ultrasound8-weeks post treatment

Percent reduction in fat layer thickness in the treated areas, as measured by ultrasound, at 8 weeks post-treatment.

Photo Review8-weeks post treatment

Comparison of pre- and 8-week post-treatment photographs to assess visible changes in contour in the treated areas.

Trial Locations

Locations (1)

Innovation Research Center

🇺🇸

Pleasanton, California, United States

Innovation Research Center
🇺🇸Pleasanton, California, United States
© Copyright 2025. All Rights Reserved by MedPath